{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:47:32Z","timestamp":1789958852582,"version":"4.0.1"},"reference-count":135,"publisher":"Maad Rayan Publishing Company","issue":"2","content-domain":{"domain":["apb.tbzmed.ac.ir"],"crossmark-restriction":false},"short-container-title":["Adv Pharm Bull"],"published-print":{"date-parts":[[2024,7,25]]},"abstract":"<jats:p>Purpose: Lymphoma, the most predominant neoplastic disorder, is divided into Hodgkin and Non-Hodgkin Lymphoma classifications. Immunotherapeutic modalities have emerged as essential methodologies in combating lymphoid malignancies. Chimeric Antigen Receptor (CAR) T cells exhibit promising responses in chemotherapy-resistant B-cell non-Hodgkin lymphoma cases. Methods: This comprehensive review delineates the advancement of CAR-T cell therapy as an immunotherapeutic instrument, the selection of lymphoma antigens for CAR-T cell targeting, and the conceptualization, synthesis, and deployment of CAR-T cells. Furthermore, it encompasses the advantages and disadvantages of CAR-T cell therapy and the prospective horizons of CAR-T cells from a computational research perspective. In order to improve the design and functionality of artificial CARs, there is a need for TCR recognition investigation, followed by the implementation of a quality surveillance methodology. Results: Various lymphoma antigens are amenable to CAR-T cell targeting, such as CD19, CD20, CD22, CD30, the kappa light chain, and ROR1. A notable merit of CAR-T cell therapy is the augmentation of the immune system\u2019s capacity to generate tumoricidal activity in patients exhibiting chemotherapy-resistant lymphoma. Nevertheless, it also introduces manufacturing impediments that are laborious, technologically demanding, and financially burdensome. Physical, physicochemical, and physiological limitations further exacerbate the challenge of treating solid neoplasms with CAR-T cells. Conclusion: While the efficacy and safety of CAR-T cell immunotherapy remain subjects of fervent investigation, the promise of this cutting-edge technology offers valuable insights for the future evolution of lymphoma treatment management approaches. Moreover, CAR-T cell therapies potentially benefit patients, motivating regulatory bodies to foster international collaboration.<\/jats:p>","DOI":"10.34172\/apb.2024.034","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T05:47:11Z","timestamp":1710568031000},"page":"314-330","update-policy":"https:\/\/doi.org\/10.34172\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management"],"prefix":"10.34172","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-3139","authenticated-orcid":true,"given":"Dito","family":"Anurogo","sequence":"first","affiliation":[{"name":"International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, 110301, Taiwan."},{"name":"Faculty of Medicine and Health Sciences, Muhammadiyah University of Makassar, Makassar, South Sulawesi, 90221, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Luthfiana","sequence":"additional","affiliation":[{"name":"Bioinformatics Research Center, Indonesian Institute of Bioinformatics (INBIO), Malang, East Java , 65162, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1588-3139","authenticated-orcid":true,"given":"Nuralfin","family":"Anripa","sequence":"additional","affiliation":[{"name":"Department of Environmental Science, Dumoga University, Kotamobagu, South Sulawesi, 95711, Indonesia."},{"name":"Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apriliani Ismi","family":"Fauziah","sequence":"additional","affiliation":[{"name":"MSc Program in Tropical Medicine, Kaohsiung Medical University, Kaohsiung City, 807378, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maratu","family":"Soleha","sequence":"additional","affiliation":[{"name":"National Research and Innovation Agency (BRIN), Central Jakarta, 10340, Indonesia."},{"name":"IKIFA College of Health Sciences, East Jakarta, Special Capital Region of Jakarta, 13470, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Rahmah","sequence":"additional","affiliation":[{"name":"Department of Digital Health, School of Medicine, Tehran University of Medical Sciences, Tehran, 1416634793, Iran."},{"name":"Faculty of Medicine, Muhammadiyah University of Surabaya, Surabaya, East Java, 60113, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Ratnawati","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Maranatha Christian University, Bandung, West Java, 40164, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Liliana","family":"Wargasetia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Maranatha Christian University, Bandung, West Java, 40164, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari Eka","family":"Pratiwi","sequence":"additional","affiliation":[{"name":"Department of Biology and Pathobiology, Faculty of Medicine, Tanjungpura University, Pontianak, West Kalimantan, 78115, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riswal Nafi","family":"Siregar","sequence":"additional","affiliation":[{"name":"National Research and Innovation Agency (BRIN), Central Jakarta, 10340, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratis Nour","family":"Sholichah","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Postgraduate School of Gadjah Mada University, Yogyakarta, 55284, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-9109","authenticated-orcid":true,"given":"Muhammad Sobri","family":"Maulana","sequence":"additional","affiliation":[{"name":"Community Health Center (Puskesmas) Temon 1, Kulon Progo, Special Region of Yogyakarta, 55654, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taruna","family":"Ikrar","sequence":"additional","affiliation":[{"name":"Director of Members-at-Large, International Association of Medical Regulatory Authorities (IAMRA), Texas, 76039, USA."},{"name":"Aivita Biomedical Inc., Irvine, California, 92612, USA."},{"name":"Chairman of Medical Council, The Indonesian Medical Council (KKI), Central Jakarta, 10350, Indonesia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Hsiang","family":"Chang","sequence":"additional","affiliation":[{"name":"International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, 110301, Taiwan."},{"name":"Locus Cell Co., LTD., Xizhi Dist., New Taipei City, 221, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-6906","authenticated-orcid":true,"given":"Jiantai Timothy","family":"Qiu","sequence":"additional","affiliation":[{"name":"International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, 110301, Taiwan."},{"name":"Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110301, Taiwan."},{"name":"Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, 110301, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20123","published-online":{"date-parts":[[2024,3,10]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.12788\/jcso.0328"},{"key":"R2","unstructured":"Jamil A, Mukkamalla SK. Lymphoma. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560826\/. Accessed May 14, 2024."},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.05.007"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21438"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2016.07.012"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1037_19"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00309-5"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681984"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0113-2"},{"key":"R10","first-page":"309","article-title":"CAR T-cell therapy for relapsed\/refractory non-Hodgkin\u2019s lymphoma: a comprehensive review","volume":"20","author":"St-Pierre F","year":"2022","journal-title":"Clin Adv Hematol Oncol"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061569"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00470"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.07.020"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28060430"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1137417"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000009648"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.7150\/thno.40606"},{"key":"R18","unstructured":"Leukemia & Lymphoma Society. Facts and Statistics [Internet]. 2015. Available from: https:\/\/tlls.org\/facts-and-statistics\/facts-and-statistics-overview\/facts-and-statistics. Accessed May 16, 2024."},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.70.9709"},{"key":"R20","unstructured":"Hodgkin Lymphoma - Cancer Stat Facts [Internet]. SEER. 2022. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/nhl.html. Accessed May 16, 2024."},{"key":"R21","unstructured":"Hodgkin Lymphoma - Cancer Stat Facts [Internet]. SEER. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html. Accessed May 16, 2024."},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1102"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-383380"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy052"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0488-6"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2018.03.001"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500751"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2015.5"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"R30","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.161.6.2791","article-title":"Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product","volume":"161","author":"Finney HM","year":"1998","journal-title":"J Immunol"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0102-70"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0758-x"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061403"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1027469"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.03.014"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-438002"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.7150\/jca.48976"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1172\/jci86000"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153618"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-283309"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0421"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-281931"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384388"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.56.2025"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.71.3024"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-128843"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf8621"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.10.002"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-16-1365"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.64.5929"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25399"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-506741"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1172\/jci86721"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14923"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1172\/jci46110"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-387969"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-686725"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2016.2"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.020"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-0426"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.09.009"},{"key":"R63","unstructured":"Couturaud B. Impact of TCR-Ligand Avidity for Viral and Tumor Antigens on Human CD8 T Cell Potency and Long-Term Persistence [dissertation]. Universit\u00e9 de Lausanne; 2019. Available from: https:\/\/gotriple.eu\/documents\/10670%2F1.kzqcbp. Accessed May 16, 2024."},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.830292"},{"key":"R65","unstructured":"Chotprakaikiat W. Development of a Novel Plant Expressed Conjugate Vaccine for HER2-Positive Breast Cancer [dissertation]. University of Southampton; 2016. Available from: https:\/\/eprints.soton.ac.uk\/400684\/. Accessed May 16, 2024."},{"key":"R66","doi-asserted-by":"crossref","unstructured":"Srivastava S, Salter AI, Liggitt D, Yechan-Gunja S, Sarvothama M, Cooper K, et al. Logic-gated ROR1 chimeric antigen receptor expression rescues T cell-mediated toxicity to normal tissues and enables selective tumor targeting. Cancer Cell 2019;35(3):489-503.e8. doi: 10.1016\/j.ccell.2019.02.003.","DOI":"10.1016\/j.ccell.2019.02.003"},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1271857"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701155"},{"key":"R69","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00417-w"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv439"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061440"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02737"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2018.77390"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168706"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718686"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0470-3"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.642528"},{"key":"R78","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2114254"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072475"},{"key":"R80","doi-asserted-by":"crossref","unstructured":"Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, et al. Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia. Cell 2018;173(6):1439-53.e19. doi: 10.1016\/j.cell.2018.05.013.","DOI":"10.1016\/j.cell.2018.05.013"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051225"},{"key":"R82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2022.05.003"},{"key":"R83","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121016"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12924"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.3390\/v13081528"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867013"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202007494"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd4344"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0006-z"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201900192"},{"key":"R91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.738456"},{"key":"R92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.947648"},{"key":"R93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.720692"},{"key":"R94","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00118"},{"key":"R95","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-016-0053-y"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2021.6910"},{"key":"R97","doi-asserted-by":"crossref","unstructured":"Tsokas K, McFarland R, Burke C, Lynch JL, Bollenbach T, Callaway DA 2nd, et al. Reducing risks and delays in the translation of cell and gene therapy innovations into regulated products. NAM Perspect 2019;2019:10.31478\/201909d. doi: 10.31478\/201909d.","DOI":"10.31478\/201909d"},{"key":"R98","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2014.78"},{"key":"R99","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000018"},{"key":"R100","doi-asserted-by":"publisher","DOI":"10.1038\/nature22395"},{"key":"R101","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2844"},{"key":"R102","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2595"},{"key":"R103","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2014.09.019"},{"key":"R104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679134"},{"key":"R105","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-519413"},{"key":"R106","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.11"},{"key":"R107","first-page":"880","article-title":"The promise of chimeric antigen receptor T-cell therapy","volume":"30","author":"Frey NV","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"R108","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.04.025"},{"key":"R109","doi-asserted-by":"publisher","DOI":"10.15419\/bmrat.v9i2.726"},{"key":"R110","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081960"},{"key":"R111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282573"},{"key":"R112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009883"},{"key":"R113","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-12-0548"},{"key":"R114","doi-asserted-by":"publisher","DOI":"10.1038\/364033a0"},{"key":"R115","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01141"},{"key":"R116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.10.019"},{"key":"R117","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1895-5"},{"key":"R118","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00921"},{"key":"R119","unstructured":"US Food & Drug Administration. Proposed Regulatory Framework for Modifications to Artificial Intelligence\/Machine Learning (AI\/ML)-Based Software as a Medical Device (SaMD) [Internet]. 2019. Available from: https:\/\/www.himss.org\/news\/proposed-regulatory-framework-modifications-artificial-intelligencemachine-learning. Accessed May 16, 2024."},{"key":"R120","doi-asserted-by":"publisher","DOI":"10.3390\/pr9020240"},{"key":"R121","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.913287"},{"key":"R122","unstructured":"Morris H, Kaltenbach T, B\u00fcnte M, Edinger D. Pharma\u2019s Big Opportunity to Ride the Next Wave | How to Enter the Cell and Gene Therapy Market [Internet]. 2021. Available from: https:\/\/rolandberger.tokyo\/rolandberger-asset\/uploads\/2022\/01\/Pharmas-big-opportunity-to-ride-the-next-wave.pdf."},{"key":"R123","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.019"},{"key":"R124","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30413-3"},{"key":"R125","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-19-2942"},{"key":"R126","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664688"},{"key":"R127","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04411-7"},{"key":"R128","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193011"},{"key":"R129","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04757-3"},{"key":"R130","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2018.01.025"},{"key":"R131","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912366"},{"key":"R132","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0078"},{"key":"R133","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02188-0"},{"key":"R134","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0977"},{"key":"R135","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1582059"}],"container-title":["Advanced Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/apb.tbzmed.ac.ir\/PDF\/apb-14-314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/apb.tbzmed.ac.ir\/PDF\/apb-14-314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T11:20:14Z","timestamp":1725362414000},"score":1,"resource":{"primary":{"URL":"https:\/\/apb.tbzmed.ac.ir\/Article\/apb-40755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,10]]},"references-count":135,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,7,25]]},"published-print":{"date-parts":[[2024,7,25]]}},"URL":"https:\/\/doi.org\/10.34172\/apb.2024.034","relation":{},"ISSN":["2228-5881","2251-7308"],"issn-type":[{"value":"2228-5881","type":"print"},{"value":"2251-7308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,10]]},"assertion":[{"value":"Tabriz University of Medical Sciences","name":"journal_owner","label":"Journal Owner"},{"value":"Tabriz University of Medical Sciences","name":"journal_publisher","label":"Journal Publisher"},{"value":"2023-03-17","order":1,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}